The first German team ever to participate in iGEM is back again and after last year's second place we're highly motivated to make some good peace of synthetic biology in 2009. In this year we want to favour you with an universal restriction enzyme to facilitate labwork and enable new techniques.
We're looking forward to meet you on this year's jamboree!
Project Summary
Restriction enzymes are proteins capable of cutting double or
single
strand nuclein acids. We focus on type II and III restriction enzymes
which at first bind the DNA strand, then recognize a certain sequence
pattern where they cut the DNA backbone. There are thousands of
different restriction enzymes, each with particular recognition and
cutting sites. These enzymes are essential tools for gene cloning and
protein expression experiments. Every medical and biological laboratory
needs to keep dozens of different restriction enzymes in stock for
regular use. Acquiring and handling so many enzymes is very expensive
and time consuming. We are determined to simplify this procedure
totally, by creating one enzyme for every occasion.
One of the biggest challenges of today is to cure diseases by means of
gene therapy. The aim here is to artifically introduce genetic
information in somatic cells to substitute DNA-sequences which may
allow the correction of mutated genes. Particularly in monogenetic
diseases this would lead to a change of the phenotype. The human genome
contains 3×10^9 bp which code for approximately 30.000
different genes.
Alone one single mutation can cause changes which may lead to diseases
or even death. Because of this it is tried in gene therapy to address
exactly these mutations. But this means that it is necessary to cause
specifically on that point a change e.g. by cutting. Restriction
enzymes could be used as high specific tools for this. But these
enzymes would have to recognize a sequence of at least 16 bp in oder to
cut only once in the human genome (416 bp = 4.3*10^9 bp). Most of the
known 3500 restriction enzymes only recognize sequences with a length
of 4-8 bp. One application of our work could be to construct an
artificial restriction enzyme with a recognition sequence of at least
16 bp of length and which is programmable for many different target
sequences.